APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dihydroartemisinin Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dihydroartemisinin Tablets Industry Growth and Trends Forecast to 2032

27 December 202593 pages

Choose your research edition.

Industry ResearchDihydroartemisinin Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Dihydroartemisinin Tablets Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Dihydroartemisinin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dihydroartemisinin Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Dihydroartemisinin Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Dihydroartemisinin Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dihydroartemisinin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dihydroartemisinin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dihydroartemisinin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dihydroartemisinin Tablets include KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Schwitz Biotech, Ipca Laboratories, Centurion Healthcare and AdvaCare Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dihydroartemisinin Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dihydroartemisinin Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dihydroartemisinin Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dihydroartemisinin Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dihydroartemisinin Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dihydroartemisinin Tablets Market by Company

KPC Pharmaceuticals

Guilin Nantang Pharmaceutical

Schwitz Biotech

Ipca Laboratories

Centurion Healthcare

AdvaCare Pharma

Dihydroartemisinin Tablets Segment by Type

Compound Dihydroartemisinin

Single Dihydroartemisinin

Dihydroartemisinin Tablets Segment by Application

Hospital Pharmacy

Retail Pharmacy

Dihydroartemisinin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dihydroartemisinin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dihydroartemisinin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dihydroartemisinin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dihydroartemisinin Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dihydroartemisinin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Compound Dihydroartemisinin Table 2. Major Company of Single Dihydroartemisinin Table 3. Global Dihydroartemisinin Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dihydroartemisinin Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Dihydroartemisinin Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dihydroartemisinin Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dihydroartemisinin Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Dihydroartemisinin Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Dihydroartemisinin Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Dihydroartemisinin Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dihydroartemisinin Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dihydroartemisinin Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Dihydroartemisinin Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Dihydroartemisinin Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Dihydroartemisinin Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dihydroartemisinin Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Dihydroartemisinin Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dihydroartemisinin Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Dihydroartemisinin Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dihydroartemisinin Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Dihydroartemisinin Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dihydroartemisinin Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Dihydroartemisinin Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Dihydroartemisinin Tablets Industry Trends Table 25. Dihydroartemisinin Tablets Industry Drivers Table 26. Dihydroartemisinin Tablets Industry Opportunities and Challenges Table 27. Dihydroartemisinin Tablets Industry Restraints Table 28. Global Dihydroartemisinin Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dihydroartemisinin Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Dihydroartemisinin Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Dihydroartemisinin Tablets Sales Share by Company (2021-2026) Table 32. Global Dihydroartemisinin Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Dihydroartemisinin Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dihydroartemisinin Tablets Major Company Production Sites and Headquarters Table 35. Global Dihydroartemisinin Tablets Company, Product Type & Application Table 36. Global Dihydroartemisinin Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dihydroartemisinin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dihydroartemisinin Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dihydroartemisinin Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Dihydroartemisinin Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dihydroartemisinin Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dihydroartemisinin Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Dihydroartemisinin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Dihydroartemisinin Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Dihydroartemisinin Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dihydroartemisinin Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dihydroartemisinin Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Dihydroartemisinin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Dihydroartemisinin Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dihydroartemisinin Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Dihydroartemisinin Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dihydroartemisinin Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dihydroartemisinin Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Dihydroartemisinin Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Dihydroartemisinin Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Dihydroartemisinin Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dihydroartemisinin Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dihydroartemisinin Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Dihydroartemisinin Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Dihydroartemisinin Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Dihydroartemisinin Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dihydroartemisinin Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Dihydroartemisinin Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dihydroartemisinin Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Dihydroartemisinin Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dihydroartemisinin Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Dihydroartemisinin Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dihydroartemisinin Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Dihydroartemisinin Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. KPC Pharmaceuticals Company Information Table 72. KPC Pharmaceuticals Business Overview Table 73. KPC Pharmaceuticals Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. KPC Pharmaceuticals Dihydroartemisinin Tablets Product Portfolio Table 75. KPC Pharmaceuticals Recent Development Table 76. Guilin Nantang Pharmaceutical Company Information Table 77. Guilin Nantang Pharmaceutical Business Overview Table 78. Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Product Portfolio Table 80. Guilin Nantang Pharmaceutical Recent Development Table 81. Schwitz Biotech Company Information Table 82. Schwitz Biotech Business Overview Table 83. Schwitz Biotech Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Schwitz Biotech Dihydroartemisinin Tablets Product Portfolio Table 85. Schwitz Biotech Recent Development Table 86. Ipca Laboratories Company Information Table 87. Ipca Laboratories Business Overview Table 88. Ipca Laboratories Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ipca Laboratories Dihydroartemisinin Tablets Product Portfolio Table 90. Ipca Laboratories Recent Development Table 91. Centurion Healthcare Company Information Table 92. Centurion Healthcare Business Overview Table 93. Centurion Healthcare Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Centurion Healthcare Dihydroartemisinin Tablets Product Portfolio Table 95. Centurion Healthcare Recent Development Table 96. AdvaCare Pharma Company Information Table 97. AdvaCare Pharma Business Overview Table 98. AdvaCare Pharma Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. AdvaCare Pharma Dihydroartemisinin Tablets Product Portfolio Table 100. AdvaCare Pharma Recent Development Table 101. North America Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Dihydroartemisinin Tablets Sales by Country (2021-2026) & (K Units) Table 103. North America Dihydroartemisinin Tablets Sales Market Share by Country (2021-2026) Table 104. North America Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Dihydroartemisinin Tablets Sales Market Share Forecast by Country (2027-2032) Table 106. North America Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Dihydroartemisinin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Dihydroartemisinin Tablets Market Share by Country (2021-2026) Table 109. North America Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Dihydroartemisinin Tablets Market Share Forecast by Country (2027-2032) Table 111. Europe Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Dihydroartemisinin Tablets Sales by Country (2021-2026) & (K Units) Table 113. Europe Dihydroartemisinin Tablets Sales Market Share by Country (2021-2026) Table 114. Europe Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Dihydroartemisinin Tablets Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Dihydroartemisinin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Dihydroartemisinin Tablets Market Share by Country (2021-2026) Table 119. Europe Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Dihydroartemisinin Tablets Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Dihydroartemisinin Tablets Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Dihydroartemisinin Tablets Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Dihydroartemisinin Tablets Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Dihydroartemisinin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Dihydroartemisinin Tablets Market Share by Country (2021-2026) Table 129. Asia-Pacific Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Dihydroartemisinin Tablets Market Share Forecast by Country (2027-2032) Table 131. Latin America Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Dihydroartemisinin Tablets Sales by Country (2021-2026) & (K Units) Table 133. Latin America Dihydroartemisinin Tablets Sales Market Share by Country (2021-2026) Table 134. Latin America Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Dihydroartemisinin Tablets Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Dihydroartemisinin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Dihydroartemisinin Tablets Market Share by Country (2021-2026) Table 139. Latin America Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Dihydroartemisinin Tablets Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Dihydroartemisinin Tablets Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Dihydroartemisinin Tablets Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Dihydroartemisinin Tablets Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Dihydroartemisinin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Dihydroartemisinin Tablets Market Share by Country (2021-2026) Table 149. Middle East and Africa Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Dihydroartemisinin Tablets Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Dihydroartemisinin Tablets Distributors List Table 154. Dihydroartemisinin Tablets Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Dihydroartemisinin Tablets Image Figure 2. Global Dihydroartemisinin Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dihydroartemisinin Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Dihydroartemisinin Tablets Sales (2021-2032) & (K Units) Figure 5. Compound Dihydroartemisinin Image Figure 6. Global Compound Dihydroartemisinin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Single Dihydroartemisinin Image Figure 8. Global Single Dihydroartemisinin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Dihydroartemisinin Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dihydroartemisinin Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Dihydroartemisinin Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Dihydroartemisinin Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Dihydroartemisinin Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dihydroartemisinin Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dihydroartemisinin Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dihydroartemisinin Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dihydroartemisinin Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dihydroartemisinin Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dihydroartemisinin Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dihydroartemisinin Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dihydroartemisinin Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacy Image Figure 24. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Dihydroartemisinin Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Dihydroartemisinin Tablets Market Share by Application 2025 VS 2032 Figure 29. North America Dihydroartemisinin Tablets Sales Market Share in Volume by Application in 2025 Figure 30. North America Dihydroartemisinin Tablets Sales Market Share in Value by Application in 2025 Figure 31. Europe Dihydroartemisinin Tablets Sales Market Share in Volume by Application in 2025 Figure 32. Europe Dihydroartemisinin Tablets Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Dihydroartemisinin Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Dihydroartemisinin Tablets Sales Market Share in Value by Application in 2025 Figure 35. Latin America Dihydroartemisinin Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Dihydroartemisinin Tablets Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Dihydroartemisinin Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Dihydroartemisinin Tablets Sales Market Share in Value by Application in 2025 Figure 39. North America Dihydroartemisinin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Dihydroartemisinin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Dihydroartemisinin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Dihydroartemisinin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Dihydroartemisinin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Dihydroartemisinin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Dihydroartemisinin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Dihydroartemisinin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Dihydroartemisinin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Dihydroartemisinin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Dihydroartemisinin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Dihydroartemisinin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Dihydroartemisinin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Dihydroartemisinin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Dihydroartemisinin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Dihydroartemisinin Tablets Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Dihydroartemisinin Tablets Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Compound Dihydroartemisinin
  • Single Dihydroartemisinin
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • KPC Pharmaceuticals
  • Guilin Nantang Pharmaceutical
  • Schwitz Biotech
  • Ipca Laboratories
  • Centurion Healthcare
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dihydroartemisinin Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dihydroartemisinin Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dihydroartemisinin Tablets Market by Type
  6. 1.3.1 Compound Dihydroartemisinin
  7. 1.3.2 Single Dihydroartemisinin
  8. 1.4 Global Dihydroartemisinin Tablets Market Size by Type
  9. 1.4.1 Global Dihydroartemisinin Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dihydroartemisinin Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dihydroartemisinin Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dihydroartemisinin Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dihydroartemisinin Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dihydroartemisinin Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dihydroartemisinin Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dihydroartemisinin Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dihydroartemisinin Tablets Industry Trends
  2. 2.2 Dihydroartemisinin Tablets Industry Drivers
  3. 2.3 Dihydroartemisinin Tablets Industry Opportunities and Challenges
  4. 2.4 Dihydroartemisinin Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dihydroartemisinin Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Dihydroartemisinin Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Dihydroartemisinin Tablets Price (2021-2026)
  4. 3.4 Global Dihydroartemisinin Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dihydroartemisinin Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Dihydroartemisinin Tablets Company, Product Type & Application
  7. 3.7 Global Dihydroartemisinin Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dihydroartemisinin Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dihydroartemisinin Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dihydroartemisinin Tablets Tier 1, Tier 2, and Tier 3
4 Dihydroartemisinin Tablets Regional Status and Outlook
  1. 4.1 Global Dihydroartemisinin Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dihydroartemisinin Tablets Historic Market Size by Region
  3. 4.2.1 Global Dihydroartemisinin Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dihydroartemisinin Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dihydroartemisinin Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dihydroartemisinin Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Dihydroartemisinin Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dihydroartemisinin Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dihydroartemisinin Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dihydroartemisinin Tablets by Application
  1. 5.1 Dihydroartemisinin Tablets Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Dihydroartemisinin Tablets Market Size by Application
  5. 5.2.1 Global Dihydroartemisinin Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Dihydroartemisinin Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Dihydroartemisinin Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Dihydroartemisinin Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Dihydroartemisinin Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Dihydroartemisinin Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Dihydroartemisinin Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Dihydroartemisinin Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 KPC Pharmaceuticals
  2. 6.1.1 KPC Pharmaceuticals Company Information
  3. 6.1.2 KPC Pharmaceuticals Business Overview
  4. 6.1.3 KPC Pharmaceuticals Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 KPC Pharmaceuticals Dihydroartemisinin Tablets Product Portfolio
  6. 6.1.5 KPC Pharmaceuticals Recent Developments
  7. 6.2 Guilin Nantang Pharmaceutical
  8. 6.2.1 Guilin Nantang Pharmaceutical Company Information
  9. 6.2.2 Guilin Nantang Pharmaceutical Business Overview
  10. 6.2.3 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Product Portfolio
  12. 6.2.5 Guilin Nantang Pharmaceutical Recent Developments
  13. 6.3 Schwitz Biotech
  14. 6.3.1 Schwitz Biotech Company Information
  15. 6.3.2 Schwitz Biotech Business Overview
  16. 6.3.3 Schwitz Biotech Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Schwitz Biotech Dihydroartemisinin Tablets Product Portfolio
  18. 6.3.5 Schwitz Biotech Recent Developments
  19. 6.4 Ipca Laboratories
  20. 6.4.1 Ipca Laboratories Company Information
  21. 6.4.2 Ipca Laboratories Business Overview
  22. 6.4.3 Ipca Laboratories Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ipca Laboratories Dihydroartemisinin Tablets Product Portfolio
  24. 6.4.5 Ipca Laboratories Recent Developments
  25. 6.5 Centurion Healthcare
  26. 6.5.1 Centurion Healthcare Company Information
  27. 6.5.2 Centurion Healthcare Business Overview
  28. 6.5.3 Centurion Healthcare Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Centurion Healthcare Dihydroartemisinin Tablets Product Portfolio
  30. 6.5.5 Centurion Healthcare Recent Developments
  31. 6.6 AdvaCare Pharma
  32. 6.6.1 AdvaCare Pharma Company Information
  33. 6.6.2 AdvaCare Pharma Business Overview
  34. 6.6.3 AdvaCare Pharma Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AdvaCare Pharma Dihydroartemisinin Tablets Product Portfolio
  36. 6.6.5 AdvaCare Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Dihydroartemisinin Tablets Sales by Country
  2. 7.1.1 North America Dihydroartemisinin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dihydroartemisinin Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dihydroartemisinin Tablets Market Size by Country
  6. 7.2.1 North America Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dihydroartemisinin Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dihydroartemisinin Tablets Sales by Country
  2. 8.1.1 Europe Dihydroartemisinin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dihydroartemisinin Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dihydroartemisinin Tablets Market Size by Country
  6. 8.2.1 Europe Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dihydroartemisinin Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dihydroartemisinin Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Dihydroartemisinin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dihydroartemisinin Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dihydroartemisinin Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dihydroartemisinin Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dihydroartemisinin Tablets Sales by Country
  2. 10.1.1 South America Dihydroartemisinin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dihydroartemisinin Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dihydroartemisinin Tablets Market Size by Country
  6. 10.2.1 South America Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dihydroartemisinin Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dihydroartemisinin Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Dihydroartemisinin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dihydroartemisinin Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dihydroartemisinin Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dihydroartemisinin Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Dihydroartemisinin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dihydroartemisinin Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dihydroartemisinin Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dihydroartemisinin Tablets Value Chain Analysis
  2. 12.1.1 Dihydroartemisinin Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dihydroartemisinin Tablets Production Mode & Process
  7. 12.2 Dihydroartemisinin Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dihydroartemisinin Tablets Distributors
  10. 12.2.3 Dihydroartemisinin Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst